minoxidil
FDA Approved
Description
Minoxidil is a vasodilator that promotes hair growth through mechanisms including prolongation of anagen phase and stimulation of hair follicles. It is used off-label for various forms of hypotrichosis including hypotrichosis simplex. Topical application has demonstrated efficacy in hereditary hair loss conditions.
Indications & Therapeutic Use
androgenetic alopecia, alopecia areata, hypotrichosis
Linked Diseases:
hypotrichosis simplex
C537160
Global Availability (9 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
minoxidil
| Generic Name | minoxidil |
| Brands | 1 brand available |
| Active Ingredient | minoxidil |
| Drug Class | androgenetic alopecia |
| Manufacturer | Johnson & Johnson |
| Dosage Forms | topical solution 2%/5%, topical foam 5% |
| Medical Code | D11AX01 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 5 days |
| Reg. Status | FDA Approved |
| Countries | 9 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations10 Validated Nodes